Geriatrics (Jul 2024)

Pisa Syndrome Secondary to Drugs: A Scope Review

  • Jamir Pitton Rissardo,
  • Nilofar Murtaza Vora,
  • Naseeb Danaf,
  • Saivignesh Ramesh,
  • Sanobar Shariff,
  • Ana Letícia Fornari Caprara

DOI
https://doi.org/10.3390/geriatrics9040100
Journal volume & issue
Vol. 9, no. 4
p. 100

Abstract

Read online

Background: Pisa syndrome, also known as pleurothotonus, is a neurological condition characterized by more than ten degrees of constant lateral curvature of the spine when upright. In this way, the present manuscript aims to systematically review Pisa syndrome secondary to drugs. Methods: Two reviewers identified and assessed relevant reports in six databases without language restriction between January 1990 and June 2024. Results: The prevalence of Pisa syndrome varied from 0.037 to 9.3%. We found 109 articles containing 191 cases of drug-induced Pisa syndrome reported in the literature. The mean and median ages were 59.70 (SD = 19.02) and 67 (range = 12–98 years). The most prevalent sex was female, 56.91% (107/188). The most frequent medications associated with Pisa syndrome were acetylcholinesterase inhibitors in 87 individuals. Of 112 individuals in which the onset time from the medication to the movement disorder occurrence was reported, 59 took place within a month. In this way, a return to baseline was observed in 45.50% of the cases, and partial recovery was observed in 14.28%. Conclusion: We proposed new diagnostic criteria for Pisa syndrome based on previous findings in the literature. Moreover, multiple mechanisms are probably involved in balance control and the development of lateral trunk flexions.

Keywords